Ezetimibe 10mg Tablets

  • Company:

    Gerard Laboratories
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may be renewed (B)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

Updated on 11 May 2023

File name

ie-pl-nl2923-v021g-v022-clean.pdf

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision
  • Change to name of medicinal product

Updated on 10 June 2022

File name

ie-pl-nl2923-v019-clean.pdf

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to name of medicinal product

Updated on 09 March 2022

File name

ie-pl-nl2923-v017-clean.pdf

Reasons for updating

  • Change to name of medicinal product

Updated on 05 November 2021

File name

ie-pl-nl2923-p001-clean.pdf

Reasons for updating

  • Change to section 3 - use in children/adolescents
  • Change to section 6 - date of revision

Updated on 28 October 2021

File name

ie-pl-nl2923-v015g-clean.pdf

Reasons for updating

  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision

Updated on 28 October 2021

File name

ie-spc-nl2923-v015g-clean.pdf

Reasons for updating

  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 26 January 2021

File name

ie-spc-nl2923-v013-v014-clean.pdf

Reasons for updating

  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 26 January 2021

File name

ie-pil-nl2923-v013-v014-clean.pdf

Reasons for updating

  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision

Updated on 11 January 2021

File name

ie-SPC-nl2923-v012-clean.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 11 January 2021

File name

ie-PIL-nl2923-v012-clean.pdf

Reasons for updating

  • Change to section 2 - excipient warnings
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Updated on 31 January 2019

File name

ezetimibe pil.pdf

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - marketing authorisation number
  • Change to section 6 - date of revision

Updated on 30 January 2019

File name

ezetimibe spc.pdf

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • Change to section 8 - Marketing authorisation number(s)
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 05 June 2018

File name

ie-combined-nl2923-clean-v006.docx

Reasons for updating

  • New SPC for medicines.ie

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 16 May 2018

File name

ie-combined-nl2923-clean-v006.docx

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 26 April 2018

File name

PIL Ezetimibe.pdf

Reasons for updating

  • New PIL for new product